Skip to content

The application value of changes of cytokines in cerebrospinal fluid and serum in patients with neurosyphilis

The application value of changes of cytokines in cerebrospinal fluid and serum in patients with neurosyphilis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078640
Enrollment
Unknown
Registered
2023-12-14
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurosyphilis

Interventions

neurosyphilis:NA

Sponsors

Hangzhou Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) confirmed diagnosis of neurosyphilis (according to the 2020 guidelines for the diagnosis and treatment of syphilis issued by the Chinese Center for Disease Control and Prevention); 2) 18 years or older 3) consent to standard antibiotic therapy for neurosyphilis.

Exclusion criteria

Exclusion criteria: 1) co-infection with HIV and other infectious diseases; 2) taking high-dose antibiotics within the past 6 months; 3) history of other mental disorders, family history, or history of taking antipsychotic drugs;; 4) serious physical diseases; 5) history of traumatic brain injury or unexplained coma; 6) long-term history of smoking and drinking.

Design outcomes

Primary

MeasureTime frame
cytokines;

Countries

China

Contacts

Public ContactShuqi Wang

Hangzhou Seventh People's Hospital

shuqiwang610@163.com+86 183 5717 2248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026